Pushkal Garg
R&D Executive
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Research and Development Officer | $767,900 | $6,490,500 |
| 2024 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Medical Officer | $682,100 | $2,919,190 |
| 2023 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Medical Officer | $656,900 | $3,231,090 |
| 2022 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Medical Officer | $625,000 | $2,900,580 |
| 2021 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Medical Officer | $568,900 | $4,047,990 |
| 2020 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Medical Officer and Executive Vice President, Development & Medical Affairs | $553,200 | $2,587,750 |
Earnings-call appearances
-
Goldman Sachs 47th Annual Global Healthcare Conference2026-06-09
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-04-30
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-02-12
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-10-30
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-07-31
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-03-31
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-01-13
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-09-30
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-03-31
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-01-08
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-02
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-08-03
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-05-04
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-02-23
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-04-28
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-10-28
Alnylam Pharmaceuticals, Inc. (ALNY)